The differences in the median daily dose of insulin between groups with neuropathy and without neuropathy proved to be statistically insignificant: 0.42 (IQR: 0.37–0.57) versus 0.56 (IQR: 0.44–0.63) units/kg of body weight/24 h, p = 0.08. This evidence concerns the gene INS and neuropathy.